Peroxisome Proliferator Activated Receptor Agonists Modulate Transposable Element Expression in Brain and Liver

Peroxisome proliferator activated receptors (PPARs) are nuclear hormone receptors that act as transcription factors in response to endogenous lipid messengers. The fibrates and thiazolidinediones are synthetic PPAR agonists used clinically to treat dyslipidemia and Type 2 Diabetes Mellitus, respecti...

Full description

Bibliographic Details
Main Authors: Laura B. Ferguson, Lingling Zhang, Shi Wang, Courtney Bridges, R. Adron Harris, Igor Ponomarev
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnmol.2018.00331/full
id doaj-73040b37a629402ea74685a44c9f838c
record_format Article
spelling doaj-73040b37a629402ea74685a44c9f838c2020-11-25T01:13:33ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992018-09-011110.3389/fnmol.2018.00331397624Peroxisome Proliferator Activated Receptor Agonists Modulate Transposable Element Expression in Brain and LiverLaura B. Ferguson0Lingling Zhang1Shi Wang2Shi Wang3Courtney Bridges4R. Adron Harris5Igor Ponomarev6Waggoner Center for Alcohol & Addiction Research, The University of Texas at Austin, Austin, TX, United StatesMOE Key Laboratory of Marine Genetics and Breeding, Ocean University of China, Qingdao, ChinaMOE Key Laboratory of Marine Genetics and Breeding, Ocean University of China, Qingdao, ChinaLaboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao, ChinaWaggoner Center for Alcohol & Addiction Research, The University of Texas at Austin, Austin, TX, United StatesWaggoner Center for Alcohol & Addiction Research, The University of Texas at Austin, Austin, TX, United StatesWaggoner Center for Alcohol & Addiction Research, The University of Texas at Austin, Austin, TX, United StatesPeroxisome proliferator activated receptors (PPARs) are nuclear hormone receptors that act as transcription factors in response to endogenous lipid messengers. The fibrates and thiazolidinediones are synthetic PPAR agonists used clinically to treat dyslipidemia and Type 2 Diabetes Mellitus, respectively, but also improve symptoms of several other diseases. Transposable elements (TEs), repetitive sequences in mammalian genomes, are implicated in many of the same conditions for which PPAR agonists are therapeutic, including neurodegeneration, schizophrenia, and drug addiction. We tested the hypothesis that there is a link between actions of PPAR agonists and TE expression. We developed an innovative application of microarray data by mapping Illumina mouse WG-6 microarray probes to areas of the mouse genome that contain TEs. Using this information, we assessed the effects of systemic administration of three PPAR agonists with different PPAR subtype selectivity: fenofibrate, tesaglitazar, and bezafibrate, on TE probe expression in mouse brain [prefrontal cortex (PFC) and amygdala] and liver. We found that fenofibrate, and bezafibrate to a lesser extent, up-regulated probes mapped to retrotransposons: Short-Interspersed Elements (SINEs) and Long-Interspersed Elements (LINEs), in the PFC. Conversely, all PPAR agonists down-regulated LINEs and tesaglitazar and bezafibrate also down-regulated SINEs in liver. We built gene coexpression networks that partitioned the diverse transcriptional response to PPAR agonists into groups of probes with highly correlated expression patterns (modules). Most of the differentially expressed retrotransposons were within the same module, suggesting coordinated regulation of their expression, possibly by PPAR signaling. One TE module was conserved across tissues and was enriched with genes whose products participate in epigenetic regulation, suggesting that PPAR agonists affect TE expression via epigenetic mechanisms. Other enriched functional categories included phenotypes related to embryonic development and learning and memory, suggesting functional links between these biological processes and TE expression. In summary, these findings suggest mechanistic relationships between retrotransposons and PPAR agonists and provide a basis for future exploration of their functional roles in brain and liver.https://www.frontiersin.org/article/10.3389/fnmol.2018.00331/fulltransposable elementsretrotransposonsPPARpsychiatricgene expression
collection DOAJ
language English
format Article
sources DOAJ
author Laura B. Ferguson
Lingling Zhang
Shi Wang
Shi Wang
Courtney Bridges
R. Adron Harris
Igor Ponomarev
spellingShingle Laura B. Ferguson
Lingling Zhang
Shi Wang
Shi Wang
Courtney Bridges
R. Adron Harris
Igor Ponomarev
Peroxisome Proliferator Activated Receptor Agonists Modulate Transposable Element Expression in Brain and Liver
Frontiers in Molecular Neuroscience
transposable elements
retrotransposons
PPAR
psychiatric
gene expression
author_facet Laura B. Ferguson
Lingling Zhang
Shi Wang
Shi Wang
Courtney Bridges
R. Adron Harris
Igor Ponomarev
author_sort Laura B. Ferguson
title Peroxisome Proliferator Activated Receptor Agonists Modulate Transposable Element Expression in Brain and Liver
title_short Peroxisome Proliferator Activated Receptor Agonists Modulate Transposable Element Expression in Brain and Liver
title_full Peroxisome Proliferator Activated Receptor Agonists Modulate Transposable Element Expression in Brain and Liver
title_fullStr Peroxisome Proliferator Activated Receptor Agonists Modulate Transposable Element Expression in Brain and Liver
title_full_unstemmed Peroxisome Proliferator Activated Receptor Agonists Modulate Transposable Element Expression in Brain and Liver
title_sort peroxisome proliferator activated receptor agonists modulate transposable element expression in brain and liver
publisher Frontiers Media S.A.
series Frontiers in Molecular Neuroscience
issn 1662-5099
publishDate 2018-09-01
description Peroxisome proliferator activated receptors (PPARs) are nuclear hormone receptors that act as transcription factors in response to endogenous lipid messengers. The fibrates and thiazolidinediones are synthetic PPAR agonists used clinically to treat dyslipidemia and Type 2 Diabetes Mellitus, respectively, but also improve symptoms of several other diseases. Transposable elements (TEs), repetitive sequences in mammalian genomes, are implicated in many of the same conditions for which PPAR agonists are therapeutic, including neurodegeneration, schizophrenia, and drug addiction. We tested the hypothesis that there is a link between actions of PPAR agonists and TE expression. We developed an innovative application of microarray data by mapping Illumina mouse WG-6 microarray probes to areas of the mouse genome that contain TEs. Using this information, we assessed the effects of systemic administration of three PPAR agonists with different PPAR subtype selectivity: fenofibrate, tesaglitazar, and bezafibrate, on TE probe expression in mouse brain [prefrontal cortex (PFC) and amygdala] and liver. We found that fenofibrate, and bezafibrate to a lesser extent, up-regulated probes mapped to retrotransposons: Short-Interspersed Elements (SINEs) and Long-Interspersed Elements (LINEs), in the PFC. Conversely, all PPAR agonists down-regulated LINEs and tesaglitazar and bezafibrate also down-regulated SINEs in liver. We built gene coexpression networks that partitioned the diverse transcriptional response to PPAR agonists into groups of probes with highly correlated expression patterns (modules). Most of the differentially expressed retrotransposons were within the same module, suggesting coordinated regulation of their expression, possibly by PPAR signaling. One TE module was conserved across tissues and was enriched with genes whose products participate in epigenetic regulation, suggesting that PPAR agonists affect TE expression via epigenetic mechanisms. Other enriched functional categories included phenotypes related to embryonic development and learning and memory, suggesting functional links between these biological processes and TE expression. In summary, these findings suggest mechanistic relationships between retrotransposons and PPAR agonists and provide a basis for future exploration of their functional roles in brain and liver.
topic transposable elements
retrotransposons
PPAR
psychiatric
gene expression
url https://www.frontiersin.org/article/10.3389/fnmol.2018.00331/full
work_keys_str_mv AT laurabferguson peroxisomeproliferatoractivatedreceptoragonistsmodulatetransposableelementexpressioninbrainandliver
AT linglingzhang peroxisomeproliferatoractivatedreceptoragonistsmodulatetransposableelementexpressioninbrainandliver
AT shiwang peroxisomeproliferatoractivatedreceptoragonistsmodulatetransposableelementexpressioninbrainandliver
AT shiwang peroxisomeproliferatoractivatedreceptoragonistsmodulatetransposableelementexpressioninbrainandliver
AT courtneybridges peroxisomeproliferatoractivatedreceptoragonistsmodulatetransposableelementexpressioninbrainandliver
AT radronharris peroxisomeproliferatoractivatedreceptoragonistsmodulatetransposableelementexpressioninbrainandliver
AT igorponomarev peroxisomeproliferatoractivatedreceptoragonistsmodulatetransposableelementexpressioninbrainandliver
_version_ 1725161561489670144